US 11053309
Methods for treating active eosinophilic esophagitis
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 11053309 (Methods for treating active eosinophilic esophagitis) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K2039/577